Published on: October 30, 2018 at 12:00PM
Conditions: Pancreatic Adenocarcinoma; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8
Interventions: Biological: Pembrolizumab; Biological: Wild-type Reovirus
Sponsors: Northwestern University; National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2qimVdv
No comments:
Post a Comment